OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1563-1575
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts
Palak Trivedi, Gideon M. Hirschfield, David H. Adams, et al.
Gastroenterology (2024) Vol. 166, Iss. 6, pp. 995-1019
Closed Access | Times Cited: 17

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62

COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
Penghui Li, Ying Liu, Ziqi Cheng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113568-113568
Open Access | Times Cited: 42

Outcomes of COVID-19 among patients with liver disease
Isidora S Vujcic
World Journal of Gastroenterology (2023) Vol. 29, Iss. 5, pp. 815-824
Open Access | Times Cited: 18

A cross-sectional study of laboratory parameters 5-6 months after the first COVID-19 infection
Taja Zore, Jasna Lojk, Katarina Reberšek, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42535-e42535
Open Access

Liver pathology in COVID-19
Svetlana F. Krasnenkova, O. V. Zayrаtyants, Konstantin Midiber, et al.
Russian Journal of Archive of Pathology (2025) Vol. 87, Iss. 1, pp. 53-53
Closed Access

A single-nucleus and spatial transcriptomic atlas of the COVID-19 liver reveals topological, functional, and regenerative organ disruption in patients
Yered Pita-Juárez, Dimitra Karagkouni, Nikolaos Kalavros, et al.
Genome biology (2025) Vol. 26, Iss. 1
Open Access

Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study
Larissa Nixdorf, Lukas Hartl, Stefanie Ströhl, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?
Chuan-Han Deng, Tianqi Li, Wei Zhang, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1451-1451
Open Access | Times Cited: 11

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
Luke Baldelli, Thomas Marjot, Eleanor Barnes, et al.
Gut and Liver (2022) Vol. 17, Iss. 1, pp. 12-23
Open Access | Times Cited: 14

Secondary Sclerosing Cholangiopathies
Michele Barnhill, Channa R. Jayasekera
Current Hepatology Reports (2024) Vol. 23, Iss. 1, pp. 145-152
Closed Access | Times Cited: 2

Arbidol attenuates liver fibrosis and activation of hepatic stellate cells by blocking TGF-β1 signaling
Younan Ren, Ying Chen, Emily H. Tang, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176367-176367
Closed Access | Times Cited: 2

Intrahepatic Cholestasis of Pregnancy during COVID-19 Pandemic
Paulina Malarkiewicz, Urszula Nowacka, Aleksandra Januszaniec, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 676-676
Open Access | Times Cited: 2

Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
Jinyu Zhao, Ping Yue, Ningning Mi, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 326-365
Closed Access | Times Cited: 2

Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19
Angus Jacobs, Steven D. Morley, Kay Samuel, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 31, pp. 3705-3716
Open Access | Times Cited: 2

COVID‐19‐associated cholangiopathy: What is left after the virus has gone?
Niklas Heucke, Verena Keitel
Hepatology (2022) Vol. 76, Iss. 6, pp. 1560-1562
Open Access | Times Cited: 13

COVID-19 and MAFLD/NAFLD: An updated review
Ali Nowroozi, Sara Momtazmanesh, Nima Rezaei
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7

Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury
Hikmet Akkız
Viruses (2023) Vol. 15, Iss. 6, pp. 1287-1287
Open Access | Times Cited: 7

Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19
Julie Henrie, Ludovic Gérard, Caroline Declerfayt, et al.
BMC Anesthesiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6

Role of microbiome in autoimmune liver diseases
Kai Markus Schneider, Martin Kummen, Palak Trivedi, et al.
Hepatology (2023) Vol. 80, Iss. 4, pp. 965-987
Open Access | Times Cited: 6

Current Therapies for Cholestatic Diseases
Nahúm Méndez‐Sánchez, Carlos E. Coronel-Castillo, Ana Luisa Ordóñez-Vázquez
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1713-1713
Open Access | Times Cited: 5

Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients
Ciro Romano, Domenico Cozzolino, Riccardo Nevola, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1904-1904
Open Access | Times Cited: 5

Post-COVID-19 cholangiopathy: Systematic review
Mazen Abdalla Rasheed, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, et al.
World Journal of Methodology (2023) Vol. 13, Iss. 4, pp. 296-322
Open Access | Times Cited: 5

Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center Study
Christoph R. Werner, Stefano Fusco, Katharina Kienzle, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 745-745
Open Access | Times Cited: 1

Page 1 - Next Page

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 1-25 of 62 citing articles:

Your Privacy